Uncategorized

FDA turns to old drugs to address new diseases, persistent medical needs

Published

on

The FDA is looking to retool drugs with sufficient evidence to support their use in other indications, particularly those with unmet need.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version